Abiopharma

🔍 Gerspach John C (Director)

Company: BREAD FINANCIAL HOLDINGS, INC. (BFH)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Acquired 483 shares of Common Stock (Direct)
  Date: 2026-04-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 47,206.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-15 | Code: H | nature_of_ownership: By Gerspach 2020 GST Exempt Trust | shares_owned_after: 6,000.00 | Footnotes: F3

Footnotes:

• F1: The new grant is for 483 shares of common stock represented by restricted stock units, which will vest on April 15, 2027.
• F2: The total amount of securities beneficially owned includes: (a) 18,762 unrestricted shares; (b) 5,981 unvested restricted stock units granted 6/22/20; (c) 2,241 unvested restricted stock units granted 6/15/21; (d) 431 unvested restricted stock units granted 9/15/21; (e) 474 unvested restricted stock units granted 12/15/21; (f) 538 unvested restricted stock units granted 3/15/22; (g) 2,650 unvested restricted stock units granted 6/15/22; (h) 934 unvested restricted stock units granted 7/15/22; (i) 969 unvested restricted stock units granted 10/17/22; (j) 912 unvested restricted stock units granted 1/17/23; (k) 1,038 unvested restricted stock units granted 4/17/23; (l) 4,932 unvested restricted stock units granted 6/15/23; (m) 1,186 unvested restricted stock units granted 7/17/23; (n) 1,033 unvested restricted stock units granted 10/16/23;
• F3: The shares are held by the Gerspach 2020 GST Exempt Trust, for which the Reporting Person's spouse serves as trustee.
• REMARKS: Footnote 2, continued: (o) 2,802 unvested restricted stock units granted 6/16/25; (p) 671 unvested restricted stock units granted 7/15/25; (q) 670 unvested restricted stock units granted 10/15/25; (r) 499 unvested restricted stock units granted 01/15/26; and (s) the new grant for 483 restricted stock units.